Drug Topics
MAY 17, 2024
While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.
STAT
MAY 20, 2024
WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT. Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 17, 2024
Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.
pharmaphorum
MAY 20, 2024
Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have a role to play in chronic obstructive pulmonary disease (COPD) – a key target indication for the drug – despite missing its primary objective in a clinical trial.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MAY 20, 2024
Six months after launching its weight loss program, online health and wellness company Hims & Hers added compounded GLP-1 medications to its offerings. | Six months after launching its weight loss program, online health and wellness company Hims & Hers added compounded GLP-1 medications to its offerings.
Drug Topics
MAY 16, 2024
Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, sat down with Drug Topics to discuss his joint business venture.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 15, 2024
Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.
Fierce Pharma
MAY 14, 2024
With new four-year data in hand, Novo Nordisk can make a case for its popular obesity med Wegovy to be used as a long-term treatment. | An analysis unveiled at the European Congress on Obesity showed that Wegovy patients lost 10% of their weight, on average, over a 4-year span.
Fierce Healthcare
MAY 15, 2024
U.S. | Senators Sheldon Whitehouse and Bill Cassidy want to reform how primary care providers get paid through Medicare, and they also want to hear from the healthcare industry about the best way to do it.
Drug Topics
MAY 14, 2024
Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MAY 20, 2024
WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning. A few senior leaders are expected to depart as part of the reorganization.
Pharmacy Times
MAY 20, 2024
Despite the finding, the authors suggest further research is done to better understand the mechanisms behind the interactions between asthma, sleep, and depression.
pharmaphorum
MAY 14, 2024
The Institute for Clinical and Economic Review (ICER) typically focuses on the cost-effectiveness of new therapies, but in an unusual move has sharply criticised the design and conduct of clinical trials of Lykos Therapeutics psychedelic therapy for post-traumatic stress disorder (PTSD).
Fierce Healthcare
MAY 17, 2024
The panel that worked on the report was made up of Big Tech players like Amazon, Google and Microsoft, as well as leaders such as Harvard Medical School, the Leapfrog Group and Kaiser Permanente.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
MAY 17, 2024
Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.
STAT
MAY 19, 2024
Removing a patient’s race from an equation used to assess lung function — a change called for by health equity advocates — would mean that the lung disease of nearly half a million Black Americans would be reclassified as being more severe, and that Black veterans could receive more than $1 billion in additional disability payments, according to a study published Sunday in the New England Journal of Medicine.
Pharmacy Times
MAY 15, 2024
The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.
The Checkup by Singlecare
MAY 20, 2024
People with attention deficit hyperactivity disorder ( ADHD ) may feel like they’re fighting a constant battle against distraction and impulsivity. Adderall can provide some much-needed help. Adderall is a central nervous system stimulant ( CNS ). It contains amphetamine and dextroamphetamine and works by increasing dopamine, serotonin, and norepinephrine.
Fierce Healthcare
MAY 15, 2024
NEW YORK CITY—Uber Health will begin rolling out a new solution designed for caregivers this summer, the company announced at its annual product event Wednesday. | Uber Caregiver will allow care-receivers to add a caregiver to their Uber profile so they can see and spend their health benefits on eligible services, request rides to doctor’s appointments or order groceries.
Drug Topics
MAY 15, 2024
The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.
STAT
MAY 20, 2024
WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him. For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’
Pharmacy Times
MAY 17, 2024
Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer.
Fierce Pharma
MAY 16, 2024
The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. With 18 of the industry’s top 25 companies achieving year-over-year revenue gains, Q1 came close to matching the final quarter of last year, when 21 of the top 25 companies showed increases.
Fierce Healthcare
MAY 20, 2024
The Department of Health and Human Services’ (HHS’) research funding agency is floating more than $50 million to developers who can build a scalable cybersecurity platform able to keep hospitals' c | The UPGRADE program will be handing out millions to those with the best pitches on how to detect hospital cybersecurity weaknesses and deploy fixes with minimal interruptions to care delivery.
Drug Topics
MAY 20, 2024
Health care providers must listen to patients who voice their experiences with post–COVID-19 condition symptoms. Only then can a clearer picture of the condition emerge for the millions of patients who have the near-invisible disease.
STAT
MAY 20, 2024
After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat. So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal.
Pharmacy Times
MAY 18, 2024
Researchers from the University of Manchester have developed a technique using rotaxane actuators in force-controlled release systems, enabling precise and efficient release of multiple molecules simultaneously.
Pharmafile
MAY 17, 2024
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.
Fierce Healthcare
MAY 14, 2024
Facing the wrath of upset investors following its first quarter earnings, CVS Health has promised to value margins over members going forward. | CVS Health is reassessing its Medicare Advantage business and weighing the possibility of exiting certain markets as it looks to get its margins under control.
Drug Topics
MAY 14, 2024
A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.
STAT
MAY 17, 2024
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down. But HIV scientists are nothing if not resilient, and used to trying one new approach after another.
Pharmacy Times
MAY 14, 2024
Corticophobia is defined as a phobia of topical corticosteroids due to negative feelings or beliefs, which can come from misinformation about the long-term effects.
Fierce Pharma
MAY 17, 2024
Seven months after Amgen’s chief medical officer referred to trial | Seven months after Amgen’s chief medical officer referred to trial results for the company's investigational lung cancer immunotherapy as a “watershed moment,” the FDA has signed off on Imdelltra (tarlatamab) to treat patients with extensive-stage small-cell lung cancer (ES-SCLC).
Fierce Healthcare
MAY 16, 2024
Earlier this month, Transcarent teased that it was betting big on artificial intelligence as it banked a $126 million funding round. | Earlier this month, Transcarent teased that it was betting big on artificial intelligence as it banked a $126 million funding round. Now, it's unveiling WayFinding, a new platform that leans on generative AI to connect members with benefits navigation, clinical guidance and care delivery services all in one place.
Expert insights. Personalized for you.
247 
Let's personalize your content